Danette Daniels, Ph.D. | Kisaco Research

 

Danette received her B.A. from Columbia University, Ph.D. in Biophysics from Yale University, and completed a postdoctoral fellowship at Stanford University School of Medicine studying Wnt signaling pathway.  She has been at Promega Corporation for 15 years and is currently an R&D Group Leader of Functional Proteomics.  She leads a team developing technologies and performing research to understand dynamic intracellular interactions within the focus areas of epigenetics, targeted protein degradation, and drug discovery.

Job Title: 
VP, Protein Degrader Platform
Company: 
Foghorn Therapeutics